D09 - Carcinoma in situ of other and unspecified sites

Version 2023
ICD-10:D09
Short Description:Carcinoma in situ of other and unspecified sites
Long Description:Carcinoma in situ of other and unspecified sites
Status: Not Valid for Submission
Version:ICD-10-CM 2023
Code Classification:
  • Neoplasms (C00–D48)
    • In situ neoplasms (D00-D09)
      • Carcinoma in situ of other and unspecified sites (D09)

D09 is a non-specific and non-billable ICD-10 code code, consider using a code with a higher level of specificity for a diagnosis of carcinoma in situ of other and unspecified sites. The code is not specific and is NOT valid for the year 2023 for the submission of HIPAA-covered transactions. Category or Header define the heading of a category of codes that may be further subdivided by the use of 4th, 5th, 6th or 7th characters.

Unspecified diagnosis codes like D09 are acceptable when clinical information is unknown or not available about a particular condition. Although a more specific code is preferable, unspecified codes should be used when such codes most accurately reflect what is known about a patient's condition. Specific diagnosis codes should not be used if not supported by the patient's medical record.

Specific Coding for Carcinoma in situ of other and unspecified sites

Non-specific codes like D09 require more digits to indicate the appropriate level of specificity. Consider using any of the following ICD-10 codes with a higher level of specificity when coding for carcinoma in situ of other and unspecified sites:

  • BILLABLE CODE - Use D09.0 for Carcinoma in situ of bladder
  • NON-BILLABLE CODE - D09.1 for Carcinoma in situ of other and unspecified urinary organs
  • BILLABLE CODE - Use D09.10 for Carcinoma in situ of unspecified urinary organ
  • BILLABLE CODE - Use D09.19 for Carcinoma in situ of other urinary organs
  • NON-BILLABLE CODE - D09.2 for Carcinoma in situ of eye
  • BILLABLE CODE - Use D09.20 for Carcinoma in situ of unspecified eye
  • BILLABLE CODE - Use D09.21 for Carcinoma in situ of right eye
  • BILLABLE CODE - Use D09.22 for Carcinoma in situ of left eye
  • BILLABLE CODE - Use D09.3 for Carcinoma in situ of thyroid and other endocrine glands
  • BILLABLE CODE - Use D09.8 for Carcinoma in situ of other specified sites
  • BILLABLE CODE - Use D09.9 for Carcinoma in situ, unspecified

Tabular List of Diseases and Injuries

The Tabular List of Diseases and Injuries is a list of ICD-10 codes, organized "head to toe" into chapters and sections with coding notes and guidance for inclusions, exclusions, descriptions and more. The following references are applicable to this diagnosis code:


Type 1 Excludes

Type 1 Excludes
A type 1 excludes note is a pure excludes note. It means "NOT CODED HERE!" An Excludes1 note indicates that the code excluded should never be used at the same time as the code above the Excludes1 note. An Excludes1 is used when two conditions cannot occur together, such as a congenital form versus an acquired form of the same condition.

Patient Education


Cancer

Cancer begins in your cells, which are the building blocks of your body. Normally, your body forms new cells as you need them, replacing old cells that die. Sometimes this process goes wrong. New cells grow even when you don't need them, and old cells don't die when they should. These extra cells can form a mass called a tumor. Tumors can be benign or malignant. Benign tumors aren't cancer while malignant ones are. Cells from malignant tumors can invade nearby tissues. They can also break away and spread to other parts of the body.

Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for where they start. For example, lung cancer starts in the lung, and breast cancer starts in the breast. The spread of cancer from one part of the body to another is called metastasis. Symptoms and treatment depend on the cancer type and how advanced it is. Most treatment plans may include surgery, radiation and/or chemotherapy. Some may involve hormone therapy, immunotherapy or other types of biologic therapy, or stem cell transplantation.

NIH: National Cancer Institute


[Learn More in MedlinePlus]

Code History